Avendran Naidu appointed Head of Commercial to lead new affiliateCNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil® ...

Teva, managed by CEO Richard Francis, is traded on the New York and Tel Aviv stock exchanges, with a market cap of $18.7 billion. Since the beginning of the year, the stock has fallen 26% after more ...

Just last week, a similar statin made headlines. Here are details on greater than 10,000 more prescription bottles now under ...

Here are nine new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.

According to the latest study from BCC Research, "Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

Explore the comprehensive Pulmonary Arterial Hypertension (PAH) market forecast, covering 68 global markets. From $10.1 billion in 2024 to $17.9 billion by 2034, the 7 major markets lead with 48% ...

The crisis over Sarepta Therapeutics' Duchenne therapy offers a valuable lesson: Listening to critics, and responding with ...

Sarepta Therapeutics faces an "arduous path” to try to get its gene therapy for Duchenne muscular dystrophy back onto the market, a senior FDA official told STAT.

Sarepta Therapeutics said on Monday it will pause all shipments of Elevidys in the United States after two teenage boys with a rare condition called Duchenne muscular dystrophy, who had received the ...